| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64f502f5061071aee475cbb88dfebf4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2005-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad2a022d9ead120e0e146bc4ad60d76a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10eccd928fdfb1d37cbd2251612de0e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7dd8cfc2e290491b9c4b6263425105 |
| publicationDate |
2008-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1945653-A2 |
| titleOfInvention |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| abstract |
The invention relates to the therapeutic use of oligonucleotides as immunostimulatory agents in immunotherapy applications. More specifically, the invention relates to an immunostimulatory oligonucleotide for use in methods of producing an immune response or methods of treating a patient in need of immunostimulation. The immunostimulatory oligonucleotides of this invention preferably comprise new purines. These immunostimulatory oligonucleotides also comprise at least two oligonucleotides linked at their 3 'termini, their internucleoside linkages, their functionalized nucleobase or their sugar to a non-nucleotide binding sequence, at least one of the oligonucleotides being an immunostimulatory oligonucleotide having a accessible termination 5 '. |
| priorityDate |
2005-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |